Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

Modern pharmaceutical companies rely on expert consulting to strengthen GMP compliance, validation, regulatory readiness, and quality systems. This guide explores the core consulting disciplines, practical selection criteria, and proven strategies that drive operational excellence throughout the pharmaceutical product lifecycle.
New analysis suggests that pharmaceutical tariffs alone may not achieve the reshoring goals many policymakers expect. According to legal and industry experts in the United States, the economics of generic drug manufacturing, combined with GMP compliance costs and validation requirements,
Roche has unveiled AXELIOS 1 Sequencing Platform, its next-generation single-molecule sequencing system powered by Sequencing by Expansion (SBX) technology. The platform delivers same-day whole-genome sequencing while combining high accuracy, flexible throughput, and near real-time analysis. The launch reflects the growing
Modern sterile manufacturing relies on integrated Sterility Assurance systems aligned with Annex 1 expectations. By combining Environmental Monitoring, Aseptic Processing, and Quality Risk Management, pharmaceutical companies reduce Cleanroom Contamination risks, prevent Cross Contamination, and strengthen GMP inspection readiness.
Orca Bio has received FDA approval for Tregzi, the first engineered regulatory T-cell therapy designed to reduce chronic GVHD following allogeneic stem cell transplantation in adults with blood cancers. While the approval marks a major clinical achievement, it also highlights
A U.S. congressional committee has launched an investigation into clinical trial activities conducted by Pfizer and Bristol Myers Squibb in China. Representative John Moolenaar raised concerns about trial sites linked to military-run facilities and regions such as Xinjiang. The inquiry
This article explains how FDA Inspection Preparation shapes GMP compliance by linking Quality Management Systems with CAPA, Data Integrity, and Risk Management. It highlights common inspection gaps and shows how companies improve readiness and reduce Form 483 findings.
Zachary Zubulake reports in PharmTech Explained that industry experts Brian Drapeau and Richard Jaenisch analyzed how AI is reshaping GMP workflows while regulators tighten scrutiny on its use in pharmaceutical manufacturing. The discussion highlights a shift in compliance expectations where